Chapter 396 Development Plan
Sunshine Biotechnology is not short of projects, technology, and talents and markets. What they lack is capital investment. After Li Tianzong enters 100 million, he can quickly revitalize the existing projects of Sunshine Biology and generate benefits as soon as possible.
Of course, not everyone believes that Li Tianzong can really bring 100 million yuan of real money. In the current situation of Sunshine Biology, ordinary investors will not easily make a large investment.
"Well, everyone is engaged in technology. You don't have to worry about the problem of capital. I have several technical problems, and I want to ask you," Li Tianzong smiled and did not talk about money, but turned the topic to technology.
Xu Qinglin's team's marketing ability is average, but his technical ability is very strong. Hearing that Li Tianzong wanted to talk about technical issues, he immediately became excited.
"Ha ha, it seems that our new boss is still very sad about technology. I don't know what kind of questions he will ask?" Xiao Zhongtian said with a smile, disapproving of the questions that Li Tianzong was about to raise.
Other people's reactions are similar to Xu Qinglin's. Biochips span several disciplines and also belong to a relatively comprehensive field, not a big street product.
However, as soon as Li Tianzong opened his mouth, he shocked these conceited experts.
Li Tianzong's professional attainments can even be affirmed by Xu Qinglin. Naturally, it is not a problem to conquer these researchers.
He did not talk about the overly professional field, but only talked about the development trend of biochip technology. In his discussion, he showed a profound understanding of this field, which was not lower than that of these researchers.
Even, some opinions made them brighten their eyes. In the past, they didn't figure it out and felt confused. After Li Tianzong's simple words, it seemed that they suddenly became enlightened.
"Mr. Li, do you look very professional?" Someone raised such a question.
Li Tianzong smiled and said, "Yes, so my investment is very cautious, but I am also very confident. I believe that my investment of 100 million yuan will definitely be worth it, because I believe in everyone's ability."
Li Tianzong's words made some researchers feel embarrassed, because they had lost most of their confidence before. Some people were thinking about leaving the sunshine and finding another way out; while some even had a mentality that no one could understand the development prospects of biochip technology. Be so clear and confident about the future.
"Don't worry, Mr. Li, we will work hard and make achievements as soon as possible!" Finally, someone came forward to make a promise.
Li Tian laughed. Although his words were very plain, the effect seemed to be okay, at least it restored everyone's confidence.
Li Tianzong knows that if you want to completely change the current situation of the company, especially the spiritual outlook of the team members, you have to make achievements as soon as possible.
With achievements, everyone will be full of confidence in the future. No matter how many words he says, it is difficult to play a role.
Li Tianzong is not in a hurry about this. He already has a specific plan. As long as this plan is implemented, the company should soon achieve some remarkable results.
The technical team of Sunshine Biology has five groups, four of which are responsible for the research and development of bioanalytical chips.
The so-called bioanalysis chip is to analyze its biological characteristics through the integration of biological particles such as genes, cells or proteins.
In short, the experiments carried out with test tubes in the biological laboratory are concentrated on a biochip, which greatly improves the efficiency of analysis.
For example, the more famous genome project uses this technical means to analyze segments of genes and collect information, so that this huge plan can be realized.
This bioanalysis chip has been widely used in biological, pharmaceutical, food research, detection and other aspects, and is a relatively mature application field.
Several bioanalytical chips developed by Sunshine Biotechnology are relatively mature in technology, and the performance of products is also very good. The problem is that these products are in the field of food safety, and the market does not agree.
Originally, Xu Qinglin saw the outbreak of food safety crises in China one after another. He thought that this aspect was a technical blank, which happened to be the place where the analysis chip could play a role. Unexpectedly, after the product came out, the effect was very good. Several potential food safety hazards can be detected, if the market If you really use this biochip to check, you can avoid many safety accidents.
Xu Qinglin ambitiously introduced these products to the market, but he didn't expect that there were few people to respond, and no one wanted them at all. In the words of a domestic food giant who was extremely impatient by Xu Qinglin, using this thing is simply a problem with himself!
The market failure of food safety detection and analysis chips can be said to be the most direct reason for the dilemma of Sunshine Biotechnology. After Li Tianzong took over the company, the first thing to do was to solve this problem, that is, to determine the company's main business direction in the future.
"Food safety testing is a very important market, but at present, it is not popular in the market. My idea is to analyze chips. We still need to focus on drug analysis. The market demand is also very large, and I am also investing in the pharmaceutical industry and can support each other," in Li Tianzong's plan. Among them, biochips and pharmaceuticals are the main direction of development in the future. There is a close relationship between the two in some aspects. Of course, it will be better to develop together.
However, compared with the acquisition of Sunshine Biology, it already has a relatively strong technical ability in biochips. Li Tianzong's acquisition of the pharmaceutical factory is not smooth. The current goal is mainly Huanghai's Kesheng Pharmaceutical. Even if the acquisition is successful, the technical force is very weak.
After all, the state's control over drugs is relatively strict. If a new drug or even a pharmaceutical factory wants to produce a new drug, it needs to go through strict and layers of tests before it can get permission. Therefore, generally, famous pharmaceutical factories are strong, which is far from what Li Tianzong can acquire now, nor can it be acquired. After winning, you will be able to catch up quickly.
If you follow the conventional approach and gradually accumulate technical strength, it will take a long time to accumulate the necessary technical strength and market, which is comparable to those old pharmaceutical manufacturers.
Li Tianzong hopes to use the technical strength of Sunshine Biotechnology to promote the improvement of pharmaceutical technology, and in turn, the demand of pharmaceutical manufacturers can be used to solve the market problems of products developed by Sunshine Biotechnology.
After meeting the company's technical team, Li Tianzong discussed the future development of the company with Sun Jingxiang, Xu Qinglin, and the original person in charge of market and technology of the company.
Xu Qinglin had a wry smile on his face: "Yes, I misread the market at the beginning and put all my resources on the food testing project, but I didn't expect it to fail in the end. The drug analysis market is more mature. Although the technical requirements are not low, it is not a problem for Sunshine Biology.
"Our problem is the market. As long as the market can digest what kind of products we can make!" Xu Qinglin has experienced the company's previous failures, but he has not lost confidence in technology.
Li Tianzong nodded: "Drug analysis will be our main direction, and food testing cannot be given up. Four groups that do analysis chips, retain one group to continue to do food testing, and three groups will change to drug analysis. In addition, we may have to take a group to do basic research on biological analysis. How to arrange it and what project to do should be determined as soon as possible!"
Li Tianzong's proposal was unanimously agreed. Xu Qinglin and others have long considered transformation, but the road ahead has gone to a dead end. It is not so simple to want to turn around. Now with Li Tianzong's large investment, it is equivalent to starting from scratch. Naturally, there is no need to think about what has been done before. Li Tianzong's plan is also safe. Just agree with one click.
"In addition, in terms of bioelectronic chips, there is now a group that continues to retain and enrich its strength as much as possible," Li Tianzong added.
The so-called bioelectronic chip is another category among biochips, in addition to analytical chips, which can be used in the manufacturing of electronic products such as biocomputers. The technology in this regard is not mature compared to analytical chips.
In the final analysis, the purpose of studying bioanalysis chips is still auxiliary pharmaceutical technology. Li Tianzong's final plan still falls on bioelectronic chips, but the current technology is not mature, so it can only be done step by step.
In Li Tianzong's view, if the biological computer can be realized and the software can run on the biological computer, there may be two results. One is to humanize the biological computer, that is, the so-called artificial intelligence, and the other is to make the software also run in the human brain, that is, to realize brain software, no In terms of which one, it is epoch-making.
Especially the latter, Li Tianzong is very clear about the anti-sky function of brain software.
Unlike the previous plan, Li Tianzong's plan to develop bioelectronic chips has been questioned, including Sun Jingxiang. Everyone believes that bioelectronic chips cannot achieve market value in the short term. When the situation of Sunshine Biology itself is not very good, it is necessary to invest in development. The project may not be too timely.
"Biocomputer is a very attractive proposal, but at present, it is very difficult to achieve it. Several countries in the world are organized by governments to organize such research projects. It can be seen that the investment is so large. With the current strength of Sunshine Biology, there is no way to carry out such a large project. We still concentrate on it. It's better to let Sunshine's business get better first..." Sun Jingxiang, from the perspective of management, believes that it is not appropriate to spread the stall too big now.
Including Xu Qinglin, several people of Sunshine Biology, although they are also optimistic about biological computer technology, who have experienced market failure, are also inclined to choose cautiously.